- Who We Are
- Lung Cancer Choices
- Living with Lung Cancer
- Resource and Fact Center
- Finding Care
- Caring Connections
- Get Involved
|Types of Clinical Trials|
Types of Clinical Trials
Most clinical trials have to go through different types of review that are designed to protect all people who take part. These reviews are conducted by scientific review panels, Institutional Review Boards (IRBs), and Data and Safety Monitoring Boards (DSMBs).
Scientific Review Panels
This panel is made up of experts who review a clinical trial protocol before it starts accepting patients to make sure it is based on sound science. All clinical trials that are funded by the Government must go through this review. Many other clinical trial sponsors, such as drug companies, also seek expert advice on the scientific merit of their trial protocols.
Institutional Review Boards
This board also reviews a clinical trial protocol before it starts accepting patients. The board members make sure the risks involved in the trial are reasonable when compared to the possible benefits. They also closely watch the ongoing progress of the trial from beginning to end.
Federal rules require that each IRB be made up of at least 5 people. One member must be from outside the institution running the trial. IRBs are usually made up of a mix of medical specialists and members of the community. Many include members from diverse careers and backgrounds. In most cases IRBs are located where the trial is to take place. Many institutions that carry out clinical trials have their own IRBs.
Data and Safety Monitoring Boards (DSMBs)
For phase III trials, DSMBs monitor the trial to help ensure your safety. They may also be appropriate and necessary for certain phase I and II clinical trials. A DSMB is an independent committee made up of statisticians, physicians, and other experts.
The Board must:
Clinical Trials Follow Strict Guidelines
The guidelines that clinical trials follow clearly state who will be able to join the study and the treatment plan. Every trial has a person in charge, usually a doctor, who is called the principal investigator. The principal investigator prepares a plan for the study, called a protocol, which is like a recipe for conducting a clinical trial. The protocol explains what the trial will do, how the study will be carried out, and why each part of the study is necessary.
It includes information on:
Who Can Join a Clinical Trial?
Based on the questions the research is trying to answer, each clinical trial protocol clearly states who can or cannot join the trial.
Common criteria for entering a trial:
Criteria such as these help ensure that people in the trial are as alike as possible. This way doctors can be sure that the results are due to the treatment being studied and not other factors.
These criteria also help ensure:
Some people have health problems besides cancer that could be made worse by the treatments in a study. If you are interested in joining a trial, you will receive medical tests to be sure that you are not put at increased risk.
Accurate and meaningful study results
You may not be able to join some clinical trials if you already have had another kind of treatment for your cancer. Otherwise, doctors could not be sure whether your results were due to the treatment being studied or the earlier treatment.
Randomization is a process used in some clinical trials to prevent bias. Bias occurs when a trial's results are affected by human choices or other factors not related to the treatments being tested. Randomization helps ensure that unknown factors do not affect trial results.
In a randomized clinical trial, you will be assigned by chance to either a control group or an investigational group. Randomization is used in all phase III and some phase II trials. These trials are called randomized clinical trials. If you participate in such a trial, you will be assigned by chance to either an investigational group or a control group. Your assignment will be determined with a computer program or table of random numbers.
If you are assigned to the control group, you will get the most widely accepted treatment (standard treatment) for your cancer.
If you are assigned to the investigational group, you will get the new treatment being tested. Comparing these groups to each other often clearly shows which treatment is more effective or has fewer side effects. If you are thinking about joining a randomized clinical trial, you need to understand that you have an equal chance to be assigned to either one of the groups. The doctor does not choose the group for you.
Will I get a placebo?
A placebo is designed to look like the medicine being tested, but it is not active. Placebos are almost never used in cancer treatment trials. In some cases, a study may compare standard treatment plus a new treatment, to standard treatment plus a placebo. You will be told if the study uses a placebo.
Federal rules help ensure that clinical trials are run in an ethical manner. Your rights and safety are protected through: Careful review and approval of the clinical trial protocol by two review panels. These panels include:
Ongoing monitoring provided during the trial by:
Informed consent is a process through which you learn the purpose, risks, and benefits of a clinical trial before deciding whether to join. It is a critical part of ensuring patient safety in research. During the informed consent process you learn important information about a clinical trial. This information can help you decide whether to join. The research team, which is made up of doctors and nurses, first explains the trial to you.
The team explains the trial's:
They will also discuss your rights, including your right to:
If you decide to leave the study, your doctor will discuss other treatment options with you. Before agreeing to take part in a trial, you have the right to:
After discussing all aspects of the study with you, the team gives you an informed consent form to read. The form includes written details about the information that was discussed and also describes the privacy of your records. If you agree to take part in the study, you sign the form. Remember, even after you sign the consent form, you can leave the study at any time.
For more information please visit Clinical Trial Resources
Educational information provided by The National Cancer Institute (NCI) Internet site.
|Last Updated on Tuesday, 24 February 2009 21:45|